Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans
Disease Models & Mechanisms · 2024
DOI: 10.1242/dmm.050524 ↗Kurz gefasst
Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2024. Verfasst von Xiaofei Bai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Florida, Gainesville, FL 32610, USA. Hauptthemen laut MEDLINE: Lipodystrophy, Congenital Generalized, Heterotrimeric GTP-Binding Proteins, GTP-Binding Protein gamma Subunits, Lipodystrophy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Seipin (BSCL2), a conserved endoplasmic reticulum protein, plays a critical role in lipid droplet (LD) biogenesis and in regulating LD morphology, pathogenic variants of which are associated with Berardinelli–Seip congenital generalized lipodystrophy type 2 (BSCL2). To model BSCL2 disease, we generated an orthologous BSCL2 variant, seip-1(A185P), in Caenorhabditis elegans. In this study, we conducted an unbiased chemical mutagenesis screen to identify genetic suppressors that restore embryonic viability in the seip-1(A185P) mutant background. A total of five suppressor lines were isolated and recovered from the screen. The defective phenotypes of seip-1(A185P), including embryonic lethality and impaired eggshell formation, were significantly suppressed in each suppressor line. Two of the five suppressor lines also alleviated the enlarged LDs in the oocytes. We then mapped a suppressor candidate gene, lmbr-1, which is an ortholog of human limb development membrane protein 1 (LMBR1). The CRISPR/Cas9 edited lmbr-1 suppressor alleles, lmbr-1(S647F) and lmbr-1(P314L), both significantly suppressed embryonic lethality and defective eggshell formation in the seip-1(A185P) background. The newly identified suppressor lines offer valuable insights into potential genetic interactors and pathways that may regulate seipin in the lipodystrophy model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Florida, Gainesville, FL 32610, USA.
- Genetics Institute, University of Florida, Gainesville, FL 32610, USA.
- National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID-Profile: Xiaofei Bai, Harold E Smith, Andy Golden
Förderung
- NIDDK NIH HHS
- NIH HHS
- NIGMS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institutes of Health
- National Institute of General Medical Sciences
- University of Florida
Zitieren
APA
Bai, X., Smith, H. E., & Golden, A. (2024). Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.050524
Vancouver
Bai X, Smith HE, Golden A. Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans. Disease Models & Mechanisms. 2024. doi:10.1242/dmm.050524
BibTeX
@article{Bai2024,
author = {Bai, Xiaofei and Smith, Harold E and Golden, Andy},
title = {Identification of genetic suppressors for a BSCL2 lipodystrophy pathogenic variant in Caenorhabditis elegans},
journal = {Disease Models & Mechanisms},
year = {2024},
doi = {10.1242/dmm.050524}
}
EUVIMED